Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
SOF/VEL/VOX effectief en veilig bij hepatitis C na falen op DAA’s
mrt 2020 | Hepatitis